Beclazone Easi-Breathe to be phased out

Teva has confirmed that they will cease supply of all strengths of Beclazone Easi-Breathe (beclometasone diproprionate) inhalers from 30 September 2009. The inhalers are being discontinued in line with the Montreal Protocol requirements to phase out manufacture of all CFC-containing beclometasone products by 2010.

Patients on Beclazone Easi-Breathe will need to be transferred to an alternative device and/or product that suits the patient.

The discontinuation does not affect Qvar Easi-Breathe or Salamol Easi-Breathe.

View Beclazone Easi-Breathe drug record

Further information: Teva

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more